PATENT CLAIM ANALYSIS

Application Number: 15988281
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "452000"]

Abstract:
The invention relates to an oral formulation for targeted delivery of cholestyramine to the colon, comprising a plurality of cholestyramine pellets that are coated with a colon release coating. The invention also relates to the use of this formulation in the treatment of bile acid malabsorption.

Claim (Index 3):
The oral dosage form of  claim 2 , wherein the pellets exhibit a friability of less than 1.5%.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.44118
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15449781', '15988560', '15449645', '11804259', '13232976']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6984812786612157
- 35 USC 102 Novelty (BERT): 0.58423928170273
- Combined Prediction Score: 0.687057078965367
- Mean Citation Score: 316.110826
- Max Citation Score: 480.7963
- Similarity Product: 414.82932918719047

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test